ACAT NP Life Sciences Health Industry Group Inc.
Services-Educational Services · OTC · SEC CIK 1781726 · Fiscal year ends 12/31
Financial factors as of 2023-12-31 (2023Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY202.8%
TTM EPS YoY—
Revenue 3-yr CAGR112.8%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-0.5%
Net margin13.4%
FCF margin—
EBITDA margin—
Returns
ROE108.6%
ROA19.0%
ROIC (approx.)—
Asset turnover1.41x
Leverage & solvency
Liabilities / assets78.7%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income-3.80x
Accruals ratio90.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $144,599 | $102,002 |
| SG&A expense | $165,311 | $120,857 |
| Operating income | -$690 | -$18,855 |
| Interest expense | $645 | $1 |
| Pretax income | -$1,335 | -$18,856 |
| Income tax | $1,600 | — |
| Net income | -$2,935 | -$18,856 |
| EPS (basic) | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 42.96M | 42.96M |
| Banking | ||
| Net interest income | — | -$1 |
| Balance sheet | ||
| Cash & equivalents | $70,614 | $121,859 |
| Total assets | $76,864 | $127,784 |
| Current liabilities | $38,121 | $108,468 |
| Total liabilities | $60,483 | $108,468 |
| Shareholders' equity | $16,381 | $19,316 |
| Shares outstanding | 42.96M | 42.96M |
| Cash flow statement | ||
| Operating cash flow | -$73,607 | $93,873 |
| Financing cash flow | $22,362 | — |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.